What is iSTAR Medical?
iSTAR Medical is a pioneering medtech firm dedicated to revolutionizing glaucoma care through the development of advanced, bio-integrative, minimally-invasive implants. Its flagship product, MINIject, stands out as the sole commercially available MIGS (minimally invasive glaucoma surgery) implant engineered to enhance natural ocular fluid dynamics, thereby ensuring safe and enduring intraocular pressure management. The company is strategically positioned to lead the global market for MIGS solutions, with its groundbreaking technology already accessible in key international markets including the European Union, the UK, Switzerland, and Australia. iSTAR Medical's mission is to significantly improve the lives of millions affected by glaucoma, a leading cause of irreversible blindness worldwide.
How much funding has iSTAR Medical raised?
iSTAR Medical has raised a total of $61.4M across 3 funding rounds:
Series A
$5.4M
Series B
$11.4M
Series C
$44.6M
Series A (2013): $5.4M with participation from Capricorn Venture Partners, Namur Invest, and Societe Regionale du2019Investissement de Wallonie
Series B (2016): $11.4M led by Capricorn Venture Partners
Series C (2019): $44.6M supported by BNP Paribas Fortis Private Equity, Walloon Region Investment Fund, Earlybird, Belgian Federal Investment Fund, Capricorn Partners, Life Sciences Partners, and Gimv
Key Investors in iSTAR Medical
Earlybird
Earlybird is a prominent European venture capital firm established in 1997, specializing in investments within the technology and medical sectors. They focus on identifying and supporting innovative European technology companies, contributing to their growth and market success.
Life Sciences Partners
Life Sciences Partners (LSP) is a leading European investment firm dedicated to the life sciences industry. They provide capital and strategic support to innovative companies across the healthcare spectrum, from early-stage biotech to established medical technology firms.
Capricorn Venture Partners
Capricorn Partners is an independent manager focused on venture capital and growth capital for innovative companies, particularly in Europe. They have a strong track record in healthtech and digital sectors, aiming to support businesses that drive positive global impact.
What's next for iSTAR Medical?
The substantial enterprise-level backing iSTAR Medical has garnered, particularly the recent strategic investment, positions the company for accelerated growth and market penetration. This infusion of capital is expected to fuel further research and development, expand manufacturing capabilities, and broaden its commercial reach into new territories. The company's focus on innovation in glaucoma treatment, a condition with a vast and growing patient population, suggests a trajectory aimed at capturing a significant share of the global ophthalmic device market. Strategic partnerships and continued product development will likely be key to solidifying its leadership in minimally invasive surgical solutions.
See full iSTAR Medical company page
